Currus Biologics

Meet the Australian VC firm with two homegrown unicorns

Profile of deep tech investor Main Sequence covering Elaine Stead's promotion to Partner, portfolio unicorns Gilmour Space and Advanced Navigation, CSIRO's expanded Atmosphere backing, and a fourth fund now being raised.

Main Sequence promotes Elaine Stead to Partner as firm builds toward Fund 4

Main Sequence announces Elaine Stead's promotion to Partner while preparing its fourth fund; CSIRO has lifted its commitment to the firm's Atmosphere pre-seed program, and two portfolio companies have reached unicorn status.

Currus Biologics Wins FDA Clearance for CUR-001 Phase 1 Trial

America's medicines regulator has approved Currus Biologics to begin human trials of CUR-001, its solid-tumour CAR T-cell therapy combination, with dosing expected from early 2027.

Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours

Australian biotech Currus Biologics has won US regulator clearance to begin human testing of its lead cancer therapy, CUR-001; the company's backers include Brandon Capital, Main Sequence and Uniseed.

Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001

Australian biotech Currus Biologics has won US regulatory clearance to begin human testing of its lead cancer therapy, CUR-001, combining an antibody platform with CAR T cells for solid tumours.

Brandon Capital's $60m taypayer-funded biotech bets

Brandon Capital has put roughly $60 million of National Reconstruction Fund money into ten biotech companies and warns R&D tax changes would hurt deep tech; portfolio company Myricx Bio went to Novartis.

Also australiatimes.com

Currus Biologics: a tale of perseverance, persistence and patience

Profile of a Peter Mac spinout advancing solid-tumour cell therapies; recounts its Series A backers, later investment, grant support, and chief executive Sam Cobb's earlier career building and listing AdAlta.

Our investment in Currus Biologics: Unlocking CAR-T for Solid Tumours

Main Sequence explains why it backed Currus Biologics, whose BEAT platform aims to make CAR-T cell therapies effective against solid tumours, starting with mesothelin-positive cancers, as the team prepares for a clinical trial.

CUREator+ Deploys $18.5 million in its First Funding Round

Eight Australian health startups received equity-free grants totaling 18.5 million dollars from the CUREator+ program, supported by government funding and delivered with partners Brandon BioCatalyst and ANDHealth.

Funding Australia’s Future Economy: CUREator Deploys $7.21 Million to Propel local Life Sciences Potential

CUREator, Brandon BioCatalyst's government-backed grant program, has awarded $7.21 million across eight Australian biotech firms in its newest round, split between clinical-stage and preclinical recipients.

Also Brandon BioCatalyst portfolio·Startup Daily·ausceleratesa.org

Australia’s first national biotech incubator announces round one funding to support life science breakthroughs

Brandon BioCatalyst's CUREator incubator names its first-round awardees, distributing government-backed funding across 23 Australian life science companies working on treatments from schizophrenia to diabetes, with round two applications now open.

Australia's first national biotech incubator announces round one funding to support life science breakthroughs

The CUREator incubator, run by Brandon BioCatalist's partner organisation, names its first-round awardees, distributing government-backed grant funding across 23 Australian life science companies developing treatments for diseases including diabetes, cancer and COPD.

Ignition Lane's Weekly Wrap: Tech's climate fight, another big raise week, valuations set to fall?

Ignition Lane's weekly technology roundup: climate-tech funding activity, Grok's bid for AGL, King River Capital's digital asset fund, a batch of Australian startup raises, Maropost acquisitions, GigSuper's collapse and a National AI Centre appointment.

Also Startup Daily

Here are the winners of the first Governor of Victoria Startup Awards

Startup Daily reports the inaugural Governor of Victoria Startup Awards, where Amber Electric and Seer Medical shared the top prize, Linktree took scaleup honours, and the Allens' Tractor Ventures won investor recognition.

Also Startup Daily

Ignition Lane Weekly Wrap: Australian space takes off, edtech learnings, Facebook hits $1 trillion

Weekly roundup reporting Gilmour Space's raise, several startup funding rounds, KKR's Education Perfect deal, ASX listings, new funds from Accel and the Albert family, and global tech listings and acquisitions.

Also Forbes Australia

The startup funding round: Beer delivery, AI-enabled upskilling, and $10 million for tech to treat cancer

Weekly roundup of Australian startup funding: Gilmour Space's $61m raise, rounds for Mindset Health, HowToo, Beer Cartel, Tracer DAO and Wimp 2 Warrior, Currus Biologics' $10m cancer-treatment raise, and Alberts' $16m impact fund.

Also Startup Daily·Startup Daily·Startup Daily·Startup Daily

Brandon Capital, Uniseed back cancer biotech start-up in $10m funding

Melbourne cancer immunotherapy startup Currus Biologics, spun out of Peter MacCallum, raised $10 million led by the Brandon Capital-managed Medical Research Commercialisation Fund with Uniseed, to advance its BEAT technology toward human trials.

Also Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·SmartCompany·Startup Daily·SmartCompany·Startup Daily